Screener
Calidi Biotherapeutics CLDI Q1 2025 Annual earnings
Reported May 14, 2025 · Before market open
EPS-$2.16Miss by $2.01
EPS estimate-$0.15
Next report
Nov 17, 2026 (in 2 months)Versus estimates
Diluted EPS
Q2 2026-$2.94Q1 2026-$0.43Q4 2025-$0.57Beat by $0.99Q3 2025-$2.21Miss by $0.53Q2 2025-$1.99Miss by $0.07
Q1 2025-$2.16Miss by $2.01
FAQ
- When did Calidi Biotherapeutics report Q1 2025 earnings?
- Calidi Biotherapeutics (CLDI) reported Q1 2025 earnings on May 14, 2025 before market open.
- What were Calidi Biotherapeutics's Q1 2025 revenue and EPS?
- Calidi Biotherapeutics reported eps of $-2.16 for Q1 2025.
- Did Calidi Biotherapeutics beat estimates in Q1 2025?
- EPS missed the consensus estimate of $-0.15 by $2.01.
- How did Calidi Biotherapeutics's Q1 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 91.2% from $-24.48.
- Where can I find Calidi Biotherapeutics's Q1 2025 SEC filings?
- You can read the 8-K earnings release (0001641172-25-010348) and the 10-K periodic report (0001641172-25-001810) directly on SEC EDGAR. The filing index links above go to sec.gov.
